Search Results - "Dam, Tomas Norman"

Interleukin-20 as a Target in Psoriasis Treatment by STENDERUP, KARIN, ROSADA, CECILIA, WORSAAE, ANNE, CLAUSEN, JES THORN, NORMAN DAM, TOMAS

“…:  Interleukin‐20 (IL‐20) is a new member of the IL‐10 cytokine family discovered by a structural algorithm. IL‐20 transgenic mice displayed skin abnormalities…”
Get full text

Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study by Schwarz, Christopher Willy, Loft, Nikolai, Rasmussen, Mads Kirchheiner, Nissen, Christoffer V., Dam, Tomas Norman, Ajgeiy, Kawa Khaled, Egeberg, Alexander, Skov, Lone

“…Identifying patient characteristics associated withachieving treatment response to biologics in patients with psoriasis could prevent expensive switching…”
Get full text

Medical specialists' use and opinion of video consultation in Denmark: a survey study by Møller, Olivia Mandal, Vange, Sif Sofie, Borsch, Anne Sofie, Dam, Tomas Norman, Jensen, Anja Mb, Jervelund, Signe Smith

“…The COVID-19 pandemic accelerated the use of telemedicine which is seen as a possibility to reduce the pressure on healthcare systems globally. However, little…”
Get full text

Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis by Loft, Nikolai Dyrberg, Skov, Lone, Rasmussen, Mads Kirchheiner, Gniadecki, Robert, Dam, Tomas Norman, Brandslund, Ivan, Hoffmann, Hans Jürgen, Andersen, Malene Rohr, Dessau, Ram Benny, Bergmann, Ann Christina, Andersen, Niels Møller, Abildtoft, Mikkel Kramme, Andersen, Paal Skytt, Hetland, Merete Lund, Glintborg, Bente, Bank, Steffen, Vogel, Ulla, Andersen, Vibeke

“…Psoriasis (PsO) is a chronic inflammatory disease with predominantly cutaneous manifestations. Approximately one third of patients with PsO develop psoriatic…”
Get full text

Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study by Loft, Nikolai Dyrberg, Egeberg, Alexander, Rasmussen, Mads Kirchheiner, Bryld, Lars Erik, Gniadecki, Robert, Dam, Tomas Norman, Iversen, Lars, Skov, Lone

“…The initiation and evaluation of treatment with biologics for psoriasis is based on the Psoriasis Area Severity Index (PASI) and/or Dermatological Life Quality…”
Get full text

Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study by Loft, Nikolai, Egeberg, Alexander, Rasmussen, Mads Kirchheiner, Bryld, Lars Erik, Nissen, Christoffer V, Dam, Tomas Norman, Ajgeiy, Kawa Khaled, Iversen, Lars, Skov, Lone

“…Early response to treatment with biologics might be important for the stability of psoriasis and long-term outcome. The aim of this study was therefore to…”
Get full text

Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries by Ahlehoff, Ole, Skov, Lone, Gislason, Gunnar, Lindhardsen, Jesper, Kristensen, Søren Lund, Iversen, Lars, Lasthein, Stine, Gniadecki, Robert, Dam, Tomas Norman, Torp-Pedersen, Christian, Hansen, Peter Riis

“…Patients with psoriasis have increased prevalence of coronary risk factors and limited recent results have suggested that these risk factors are undertreated…”
Get full text

Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries by Davila-Seijo, Paula, Garcia-Doval, Ignacio, Naldi, Luigi, Cazzaniga, Simone, Augustin, Matthias, Rustenbach, Stephan J, Daudén, Esteban, Dam, Tomas Norman, Baker, Chris, Spuls, Phyllis I, Stern, Robert S, Cohen, Arnon D

Get full text

Valrubicin in a Topical Formulation Treats Psoriasis in a Xenograft Transplantation Model by Rosada, Cecilia, Stenderup, Karin, de Darkó, Elisabeth, Dagnaes-Hansen, Frederik, Kamp, Søren, Dam, Tomas Norman

“…Valrubicin is a cytostatic drug currently approved by the American Federal Drug Administration as a trademarked Valstar sterile solution for the treatment of…”
Get full text

Statistical evaluation and experimental design of a psoriasis xenograft transplantation model treated with cyclosporin A by Stenderup, Karin, Rosada, Cecilia, Alifrangis, Lene, Andersen, Søren, Dam, Tomas Norman

“…:  Psoriasis xenograft transplantation models where human skin is transplanted onto immune‐deficient mice are generally accepted in psoriasis research. Over…”
Get full text

Application of stereology to dermatological research by Kamp, Søren, Jemec, Gregor Borut Ernst, Kemp, Kåre, Kjeldsen, Cecilia Rosada, Stenderup, Karin, Pakkenberg, Bente, Dam, Tomas Norman

“…:  Stereology is a set of mathematical and statistical tools to estimate three‐dimensional (3‐D) characteristics of objects from regular two‐dimensional (2‐D)…”
Get full text

Pan-selectin antagonism improves psoriasis manifestation in mice and man by FRIEDRICH, Markus, BOCK, Daniel, ZAHLTEN, Rainer, STERRY, Wolfram, WOLFF, Gerhard, PHILIPP, Sandra, LUDWIG, Nina, SABAT, Robert, WOLK, Kerstin, SCHROETER-MAAS, Sabine, AYDT, Ewald, KANG, Sewon, DAM, Tomas Norman

“…The selectin family of vascular cell adhesion molecules is comprised of structurally related carbohydrate binding proteins, which mediate the initial rolling…”
Get full text

Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis by Loft, Nikolai, Egeberg, Alexander, Rasmussen, Mads Kirchheiner, Bryld, Lars Erik, Nissen, Christoffer Valdemar, Dam, Tomas Norman, Ajgeiy, Kawa Khaled, Iversen, Lars, Skov, Lone

“…The efficacy of adalimumab biosimilars is similar to that of brand-name adalimumab (Humira, hereinafter originator) in clinical trials. However, limited…”
Get more information

Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study by Nielsen, Mia-Louise, Thein, David, Rasmussen, Mads Kirchheiner, Bertelsen, Trine, Dam, Tomas Norman, Skov, Lone, Bryld, Lars Erik, Wu, Jashin J., Thomsen, Simon Francis, Thyssen, Jacob P., Egeberg, Alexander

Get full text

Debio 0932, a new oral Hsp90 inhibitor, alleviates psoriasis in a xenograft transplantation model by Stenderup, Karin, Rosada, Cecilia, Gavillet, Bruno, Vuagniaux, Grégoire, Dam, Tomas Norman

“…Debio 0932 is a novel oral heat shock protein 90 (Hsp90) inhibitor developed for anti-cancer therapy. Surprising-ly, during the first clinical trial, one…”
Get full text

Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin diseases by Laugesen, Ina Groenkjaer, Hauge, Eva, Andersen, Stine Maria, Stenderup, Karin, de Darkó, Elisabeth, Dam, Tomas Norman, Rosada, Cecilia

“…Valrubicin is a semisynthetic anthracycline developed as an anti-cancer drug able to ameliorate psoriasis and non-melanoma skin cancer (NMSC) by topical…”
Get more information

Statistical evaluation and experimental design of a psoriasis xenograft transplantation model treated with cyclosporin A: Statistical evaluation of psoriasis xenograft transplantation model by Stenderup, Karin, Rosada, Cecilia, Alifrangis, Lene, Andersen, Søren, Dam, Tomas Norman

Get full text

The Danish Nonmelanoma Skin Cancer Dermatology Database by Lamberg, Anna Lei, Sølvsten, Henrik, Lei, Ulrikke, Vinding, Gabrielle Randskov, Stender, Ida Marie, Jemec, Gregor Borut Ernst, Vestergaard, Tine, Thormann, Henrik, Hædersdal, Merete, Dam, Tomas Norman, Olesen, Anne Braae

“…The Danish Nonmelanoma Skin Cancer Dermatology Database was established in 2008. The aim of this database was to collect data on nonmelanoma skin cancer (NMSC)…”
Get full text

Interleukin-20--a new target in psoriasis treatment by Stenderup, Karin, Rosada, Cecilia, Dam, Tomas Norman

“…Interleukin-20 (IL-20) is suggested as a new target in psoriasis treatment. It was first described in 2001, and the potential role of this cytokine in…”
Get more information

1α,25-Dihydroxycholecalciferol and Cyclosporine Suppress Induction and Promote Resolution of Psoriasis in Human Skin Grafts Transplanted on to SCID Mice by Dam, Tomas Norman, Kang, Sewon, Voorhees, J.J., Nickoloff, Brian J.

“…Accumulating evidence has emphasized the importance of immunocompetent cells in determining the psoriatic phenotype. We have investigated the effect of…”
Get full text